FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 310:1141-1146 May 3, 1984 Number 18 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The cerebrohepatorenal (Zellweger) syndrome is a fatal autosomal recessive disorder manifested in the neonatal period by profound hypotonia, psychomotor retardation, dysmorphic features, and an enlarged liver. In this study we demonstrate fivefold or greater increases of very-long-chain fatty acid levels, particularly hexacosanoic acid (C26:0) and hexacosenoic acid (C26:1), in plasma and cultured skin fibroblasts from 20 patients. Similar findings in cultured amniocytes from 3 of 14 women in whom the fetus was at risk of the Zellweger syndrome permitted prenatal diagnosis. Oxidation of very-long-chain fatty acids, which normally takes place in the peroxisome, was impaired in homogenates of cultured skin fibroblasts and amniocytes. This observation extends the evidence that the Zellweger syndrome belongs to the newly formulated category of peroxisomal disorders. The pattern of excess very-long-chain fatty acids differs from that demonstrated previously in patients with childhood adrenoleukodystrophy. The study of very-long-chain fatty acids provides a convenient method for the early diagnosis and prenatal detection of the Zellweger syndrome.

This article has been cited by other articles:

• Al-Dirbashi, O. Y., Santa, T., Rashed, M. S., Al-Hassnan, Z., Shimozawa, N., Chedrawi, A., Jacob, M., Al-Mokhadab, M. (2008). Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders. J. Lipid Res. 49: 1855-1862 [Abstract] [Full Text]  
• Mochel, F., Grebille, A.-G., Benachi, A., Martinovic, J., Razavi, F., Rabier, D., Simon, I., Boddaert, N., Brunelle, F., Sonigo, P. (2006). Contribution of Fetal MR Imaging in the Prenatal Diagnosis of Zellweger Syndrome.. Am. J. Neuroradiol. 27: 333-336 [Abstract] [Full Text]  
• Furuya, T., Kessler, P., Jardim, A., Schnaufer, A., Crudder, C., Parsons, M. (2002). Glucose is toxic to glycosome-deficient trypanosomes. Proc. Natl. Acad. Sci. USA 99: 14177-14182 [Abstract] [Full Text]  
• Martinez, M., Vazquez, E., Garcia-Silva, M T., Manzanares, J., Bertran, J. M, Castello, F., Mougan, I. (2000). Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders1. Am. J. Clin. Nutr. 71: 376S-385S [Abstract] [Full Text]  
• Sandhir, R., Khan, M., Chahal, A., Singh, I. (1998). Localization of nervonic acid ß-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J. Lipid Res. 39: 2161-2171 [Abstract] [Full Text]  
• Nagan, N., Hajra, A. K., Das, A. K., Moser, H. W., Moser, A., Lazarow, P., Purdue, P. E., Zoeller, R. A. (1997). A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase: A novel defect in plasmalogen biosynthesis. Proc. Natl. Acad. Sci. USA 94: 4475-4480 [Abstract] [Full Text]  
• Fan, C.-Y., Pan, J., Chu, R., Lee, D., Kluckman, K. D., Usuda, N., Singh, I., Yeldandi, A. V., Rao, M. S., Maeda, N., Reddy, J. K. (1996). Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene. J. Biol. Chem. 271: 24698-24710 [Abstract] [Full Text]  
• Street, J. M., Evans, J. E., Natowicz, M. R. (1996). Glucuronic Acid-conjugated Dihydroxy Fatty Acids in the Urine of Patients with Generalized Peroxisomal Disorders. J. Biol. Chem. 271: 3507-3516 [Abstract] [Full Text]  
• Pietrzyk, J. J., Turowska-Heydel, D., Klimek, M., Kaczmarski, F., Kaluza, J. (1990). Two Siblings with Phenotypes Mimicking Peroxisomal Disorders but with Discordant Biochemical Findings. CLIN PEDIATR 29: 479-484 [Abstract]  
• Singh, I., Johnson, G. H., Brown, F. R. III (1988). Peroxisomal Disorders: Biochemical and Clinical Diagnostic Considerations. Arch Pediatr Adolesc Med 142: 1297-1301 [Abstract]  
• Talwar, D., Swaiman, K. F. (1987). Peroxisomal Disorders: A Review of a Recently Recognized Group of Clinical Entities. CLIN PEDIATR 26: 497-504 [Abstract]  
• Goldfischer, S, Collins, J, Rapin, I, Coltoff-Schiller, B, Chang, C., Nigro, M, Black, V., Javitt, N., Moser, H., Lazarow, P. (1985). Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science 227: 67-70 [Abstract]